MENINGOCOCCAL POLYSACCHARIDE VACCINATION OF MILITARY RECRUITS IN ISRAEL - PRELIMINARY ASSESSMENT OF VACCINE EFFECT

Authors
MIMOUNI D GDALEVICH M MANDEL Y HAIM M ASHKENAZI I SHEMER J BLOCK C
Citation
D. Mimouni et al., MENINGOCOCCAL POLYSACCHARIDE VACCINATION OF MILITARY RECRUITS IN ISRAEL - PRELIMINARY ASSESSMENT OF VACCINE EFFECT, Scandinavian journal of infectious diseases, 30(3), 1998, pp. 263-264
Citations number
7
Categorie Soggetti
Infectious Diseases
Journal title
Scandinavian journal of infectious diseases → ACNP
ISSN journal
00365548
Volume
30
Issue
3
Year of publication
1998
Pages
263 - 264
Database
ISI
SICI code
0036-5548(1998)30:3<263:MPVOMR>2.0.ZU;2-C
Abstract
Meningococcal disease in the Israel Defense Force is caused mainly by serogroups C and Y. Immunization of recruits with quadrivalent polysac charide vaccine was introduced in November 1994. The person-time incid ence rate dropped from 1.33 cases per 100000 person-gears for the prec eding decade to 0 for the 32 months following immunization (p = 0.025) .